Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 984 entries
View as:

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

Phase: N/A Priority: Normal
NCT ID: NCT06581328 Org: User:
Start: 03/27/25 End: 06/01/28 Due: 06/01/29

A Study to Explore Hereditary Angioedema (HAE) Symptoms and Treatment Patterns in Korean People

Phase: N/A Priority: Normal
NCT ID: NCT06587464 Org: User:
Start: 10/16/24 End: 12/18/24 Due: 12/18/25

Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00672802 Org: User:
Start: 08/31/03 End: 03/31/04 Due: 03/31/05

Retrospective Study on Participants With Short Bowel Syndrome and Chronic Intestinal Failure That Underwent Transplantation in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT05113082 Org: User:
Start: 05/21/22 End: 10/15/22 Due: 10/15/23

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05156983 Org: User:
Start: 08/24/22 End: 04/12/28 Due: 04/12/29

A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)

Phase: N/A Priority: Normal
NCT ID: NCT03984097 Org: User:
Start: 07/29/19 End: 03/31/26 Due: 03/31/27

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02219256 Org: User:
Start: 08/31/14 End: 04/30/16 Due: 04/30/17

A Study of Vedolizumab in Adults With Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT05192863 Org: User:
Start: 03/20/23 End: 10/31/25 Due: 10/31/26

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT01452711 Org: User:
Start: 11/30/11 End: 12/31/12 Due: 12/31/13

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

Phase: N/A Priority: Normal
NCT ID: NCT01945242 Org: User:
Start: 03/31/11 End: 06/30/14 Due: 06/30/15

Triple Combination Therapy in High Risk Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT02764762 Org: User:
Start: 04/18/17 End: 07/05/22 Due: 07/05/23

Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00677053 Org: User:
Start: 03/31/08 End: 06/30/10 Due: 06/30/11

Azilsartan Tablets Special Drug Use Surveillance: Long-term Use

Phase: N/A Priority: Normal
NCT ID: NCT02092025 Org: User:
Start: 06/20/12 End: 01/15/16 Due: 01/15/17

Epidemiologic Study Of Diabetes And Cancer Risk

Phase: N/A Priority: Normal
NCT ID: NCT02958995 Org: User:
Start: 01/01/97 End: 05/29/15 Due: 05/29/16

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

Phase: N/A Priority: Normal
NCT ID: NCT00672919 Org: User:
Start: 11/30/03 End: 08/31/04 Due: 08/31/05

Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00532558 Org: User:
Start: 10/31/07 End: 05/31/08 Due: 05/31/09

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00695955 Org: User:
Start: 06/30/07 End: 05/31/10 Due: 05/31/11

Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"

Phase: N/A Priority: Normal
NCT ID: NCT03727139 Org: User:
Start: 11/01/18 End: 10/31/21 Due: 10/31/22

Post-Marketing Study of Prucalopride Safety In Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT04869280 Org: User:
Start: 05/21/21 End: 05/31/26 Due: 05/31/27

Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00770952 Org: User:
Start: 12/31/06 End: 12/31/08 Due: 12/31/09

A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03329209 Org: User:
Start: 03/05/18 End: 09/05/18 Due: 09/05/19

Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00471094 Org: User:
Start: 05/31/07 End: 10/31/07 Due: 10/31/08

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02038907 Org: User:
Start: 03/28/14 End: 06/19/15 Due: 06/19/16

Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

Phase: N/A Priority: Normal
NCT ID: NCT03555578 Org: User:
Start: 11/02/17 End: 08/31/25 Due: 08/31/26

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03596866 Org: User:
Start: 04/19/19 End: 09/12/24 Due: 09/12/25